Recent Finacing
Recent Raise
Hyloris Pharmaceuticals of Liège develops reformulations of approved drugs via FDA 505(b)(2), focusing on IV cardiovascular, other reformulations and high-barrier generics; commercial Sotalol IV and Maxigesic IV.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
